GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Conformis Inc (NAS:CFMS) » Definitions » 14-Day RSI

Conformis (Conformis) 14-Day RSI : 74.22 (As of May. 05, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Conformis 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-05), Conformis's 14-Day RSI is 74.22.

The industry rank for Conformis's 14-Day RSI or its related term are showing as below:

CFMS's 14-Day RSI is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 49 vs CFMS: 74.22

Competitive Comparison of Conformis's 14-Day RSI

For the Medical Devices subindustry, Conformis's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Conformis's 14-Day RSI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Conformis's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Conformis's 14-Day RSI falls into.



Conformis  (NAS:CFMS) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Conformis  (NAS:CFMS) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Conformis 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Conformis's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Conformis (Conformis) Business Description

Traded in Other Exchanges
N/A
Address
600 Technology Park Drive, Billerica, MA, USA, 01821
Conformis Inc is a United States-based medical technology company. It uses the iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped to fit each patient's anatomy. The company's iFit technology platform comprises three key elements which are iFit design, iFit printing, and iFit just-in-time delivery. It offers various partial and total knee replacement implants which include iTotal CR, iTotal PS, iDuo, and iUni. The company operates in the segment of the knee replacement market. Its total revenue is generated from the sale of its products to hospitals and other medical facilities. The majority of the company's revenue comes from the United States.
Executives
Christine Desrochers officer: Fmr Interim CFO & Controller 600 TECHNOLOGY PARK DRIVE, 4TH FLOOR, BILLERICA MA 01821
Gary P Fischetti director 600 TECHNOLOGY PARK DRIVE, 4TH FLOOR, BILLERICA MA 01821
Mark A Augusti director, officer: FORMER PRESIDENT & CEO 40 WEST HIGHLAND PARK DRIVE NE, HUTCHINSON MN 55350
Denise E Pedulla officer: FORMER CLO & SECRETARY 12701 COMMONWEALTH DRIVE, SUITE 9, FORT MYERS FL 33913
Philip W Johnston director C/O CONFORMIS INC, 600, BILLERICA MA 01821
Carrie Bienkowski director C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
Robert S Howe officer: CFO & TREASURER C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
J Brent Alldredge officer: CLO & SECRETARY C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
Fallon Kenneth P Iii director 5473 FOX HOLLOW DRIVE, NAPLES FL 34101
Erin Henry officer: CORP CONTROLLER & INTERIM PAO C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 01821
Frederick W Driscoll officer: INTERIM CFO & INTERIM TREAS
Paul S Weiner officer: Chief Financial Officer C/O CONFORMIS INC, 28 CROSBY DRIVE, BEDFORD MA 01730
Archon Capital Management Llc 10 percent owner 1100 19TH AVENUE EAST, SEATTLE WA 98112
Patricia A Davis officer: CLO & GENERAL COUNSEL C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA MA 02181
Bradley Langdale director C/O CONFORMIS, INC., 28 CROSBY DRIVE, BEDFORD MA 01730